Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
Core EBITDA Growth

    Back to All Ratios
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

INDOCO REMEDIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -58.96-11.62-12.4444.9880.98

What is the latest Core EBITDA Growth ratio of INDOCO REMEDIES ?

The latest Core EBITDA Growth ratio of INDOCO REMEDIES is -58.96 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-58.96
Mar2024-11.62
Mar2023-12.44
Mar202244.98
Mar202180.98

How is Core EBITDA Growth of INDOCO REMEDIES Trending?

Years Core EBITDA Growth % Change
Mar2025 -58.96
Negative
Mar2024 -11.62
Negative
Mar2023 -12.44
Negative
Mar2022 44.98
-44.46
Mar2021 80.98 -

Other Financial Ratios of INDOCO REMEDIES


Compare Core EBITDA Growth ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,005.2 Cr 8.4% 8.8% -7.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,243.0 Cr -1.4% -7.2% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,179.0 Cr 5.7% 0.3% 14.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,670.0 Cr 1.5% -6.5% 28.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,932.0 Cr 0.7% -7.4% 9.9% Stock Analytics
CIPLA ₹99,417.9 Cr 0.5% -7.1% -14.4% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

8.4%

8.8%

-7.4%

SENSEX

0.6%

1.5%

6.6%


You may also like the below Video Courses